Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Clinical Research Trial Comparing the Incidence of Preeclampsia Between Pregnant Women Receiving Tdap Vaccinations at Week 28 and Those Receiving Tdap Vaccinations at Week 36

NCT04424693 is registered in ClinicalTrials.gov with Institute of Arthritis Research as lead sponsor.

NCT NCT04424693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04424693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Clinical Research Trial Comparing the Incidence of Preeclampsia Between Pregnant Women Receiving Tdap Vaccinations at Week 28 and Those Receiving Tdap Vaccinations at Week 36
Lead sponsor
Institute of Arthritis Research
Phase
Phase 4
Overall status
Unknown status
Start date
December 1, 2020
Completion date
December 31, 2024
Enrollment
1,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diphtheria, tetanus and pertussis vaccine reaction, pre-eclampsia